Janux Therapeutics Inc (JANX)

Deferred Revenue

$35.07M

Quarterly · Period ending: · USD

JANX logo

JANX Deferred Revenue

Latest reported$35.07M
JANX Quarterly Deferred Revenue ($1.95M → $35.07M)
High-resolution chart · PNG

JANX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Janux Therapeutics Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
35,070,000
37,591,000
0
0
0
0
0
0
94,000
972,000
1,705,000
3,648,000
5,340,000
4,935,000
5,406,000
5,906,000
5,371,000
4,649,000
5,163,000
5,264,000
5,065,000
3,646,000
1,950,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.